Impella (Abiomed, Danvers, MA) is an effective option for emergent treatment of critical
refractory cardiogenic shock. However, in patients who have inadequate peripheral arterial …

Despite medical advancements in treatment of cardiogenic shock, it still remains as a
condition with highmorbidity and mortality. There are many treatment modalities to help the …

Background In patients with cardiogenic shock the clinical treatment often involves
temporary mechanical circulatory support for initial haemodynamic stabilization to enable …

Acute myocardial infarction (AMI) resulting in cardiogenic shock continues to be a
substantial source of morbidity and mortality despite advances in recognition and treatment …

INTRODUCTION Only a few cases of biventricular cardiogenic shock have been treated with
Impella circulatory assist devices in the United States. CLINICAL FINDINGS A 29-year-old …

The importance of temporary mechanical circulatory support for treating acute heart failure
with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA …

Introduction Percutaneous mechanical circulatory support systems have increasingly been
adopted as a bail out strategy in patients with cardiogenic shock. Since studies showed …

Background The treatment of cardiogenic shock with percutaneous mechanical circulatory
support (MCS) is attractive: however, at present it is not clear which is the best strategy, as …

Background Impella 5.0 is a powerful mechanical circulatory support device placed into the
left ventricle of patients in cardiogenic shock not responding to pharmacologic support …

Abstract Background Bedside insertion of Impella percutaneous ventricular assistant device
(pVAD)(Abiomed, Danvers, MA) under transesophageal echocardiographic (TEE) guidance …